Publicaciones en colaboración con investigadores/as de University of Verona (22)

2024

  1. Metastatic outgrowth via the two-way interplay of autophagy and metabolism

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 3

  2. The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives

    Seminars in Cancer Biology, Vol. 99, pp. 24-44

  3. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

    Cell Communication and Signaling, Vol. 22, Núm. 1

2021

  1. Editorial: Novel Cancer Treatments Based on Autophagy Modulation

    Frontiers in Pharmacology

2020

  1. Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells

    Archives of Biochemistry and Biophysics, Vol. 679

  2. Mutant p53-associated molecular mechanisms of ROS regulation in cancer cells

    Biomolecules, Vol. 10, Núm. 3

  3. Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment

    Frontiers in Pharmacology, Vol. 11

2019

  1. Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches

    Oxidative medicine and cellular longevity

  2. Sestrins as a therapeutic bridge between ros and autophagy in cancer

    Cancers, Vol. 11, Núm. 10

  3. Sestrins at the interface of ROS control and autophagy regulation in health and disease

    Oxidative Medicine and Cellular Longevity, Vol. 2019

2018

  1. Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2ˉ· production in cancer cells

    British Journal of Cancer, Vol. 119, Núm. 8, pp. 994-1008

2017

  1. Molecular interplay between mutant p53 proteins and autophagy in cancer cells

    Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1867, Núm. 1, pp. 19-28

  2. Onconase dimerization through 3D domain swapping: Structural investigations and increase in the apoptotic effect in cancer cells*

    Biochemical Journal, Vol. 474, Núm. 22, pp. 3767-3781

  3. UCP2 inhibition induces ROS/Akt/mTOR axis: Role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism

    Free Radical Biology and Medicine, Vol. 113, pp. 176-189

2016

  1. Mutant p53 and mTOR/PKM2 regulation in cancer cells

    IUBMB Life, pp. 722-726

  2. Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis

    Cancer Letters, Vol. 376, Núm. 2, pp. 303-309

  3. Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition

    Molecular Oncology, Vol. 10, Núm. 7, pp. 1008-1029

  4. The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition

    Free Radical Biology and Medicine, Vol. 101, pp. 305-316

2015

  1. Antioxidant mechanisms and ROS-related MicroRNAs in cancer stem cells

    Oxidative Medicine and Cellular Longevity, Vol. 2015

  2. Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1853, Núm. 1, pp. 89-100